Found: The first application is from Yasmin Qureshi and the all-party parliamentary group on hormone pregnancy

Found: Cumberlege and published on 8 July 2 020. 10.The IMMDS Review explored issues relating to the use of hormone

Found: the safety of treatments , specifically looking into cases of pelvic mesh , sodium valproate and hormone

Found: Tax-free Shopping for International Visitors Westminster Hall 0.5 38 61 (23) 7 September 2023 (1) Hormone

Found: • Sir Geoffrey Clifton- Brown: VAT reclaim on foreign shopping • Yasmin Qureshi, Hannah Bardell: Hormone

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she plans to take steps to implement recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered because of using Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group (EWG) conducted a comprehensive review of the available scientific evidence and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs and a possible causal association with adverse pregnancy outcomes.

On the recently published recommendations of the HPT All-Party Parliamentary Group, we have no plans to set up an independent review to examine the findings of the EWG. In the interests of transparency, all evidence collected and papers considered by the EWG were published in 2018, along with full minutes of its discussions. Details of conflicts of interests and how these were managed were also published. The Government is reviewing Professor Danielsson’s publication to consider if it presents any new evidence or analyses not already considered by the EWG on HPTs, and will be seeking independent expert advice from the Commission on Human Medicines in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her Department’s policies of the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will implement the recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to take steps to secure financial redress for the victims of Primodos.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government published its response to the Independent Medicines and Medical Devices Safety (IMMDS) review in July 2021, which did not accept the recommendation to establish separate redress schemes for the three interventions covered by the review. This included a redress scheme for those harmed by Primodos.

Our priority is to make medicines and devices safer, and the Government is pursuing a wide range of activity to further this aim. The 2021 response, and the Government’s December 2022 update to the response, explains the changes that have been put in place since the IMMDS Review report’s publication, and the further action the Government will take to implement the recommendations accepted and to improve patient safety.

In the recent House of Commons debate of 7 September 2023 on hormone pregnancy tests, I committed to review the outstanding recommendations in relation to Primodos.

Found: Debate on hormone pregnancy tests

Found: request, dated November 21st 2023 , where you asked for information about how the call for evidence on Hormone

Found: also stated that t hey will review any new scientific evidence which may come to light in relation to hormone